Goldman Sachs’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.37M | Buy |
3,090,068
+964,148
| +45% | +$2.61M | ﹤0.01% | 2399 |
|
|
2025
Q1 | $4.78M | Buy |
2,125,920
+6,068
| +0.3% | +$13.7K | ﹤0.01% | 2782 |
|
|
2024
Q4 | $7.42M | Buy |
2,119,852
+111,471
| +6% | +$390K | ﹤0.01% | 2551 |
|
|
2024
Q3 | $8.25M | Sell |
2,008,381
-499,132
| -20% | -$2.05M | ﹤0.01% | 2413 |
|
|
2024
Q2 | $9.03M | Buy |
2,507,513
+263,699
| +12% | +$949K | ﹤0.01% | 2156 |
|
|
2024
Q1 | $7.4M | Buy |
2,243,814
+220,142
| +11% | +$726K | ﹤0.01% | 2290 |
|
|
2023
Q4 | $4.67M | Hold |
2,023,672
| – | – | ﹤0.01% | 2640 |
|
|
2023
Q3 | $2.61M | Buy |
2,023,672
+41,266
| +2% | +$53.2K | ﹤0.01% | 2921 |
|
|
2023
Q2 | $2.62M | Sell |
1,982,406
-280,379
| -12% | -$370K | ﹤0.01% | 3030 |
|
|
2023
Q1 | $1.6M | Sell |
2,262,785
-31,981
| -1% | -$22.6K | ﹤0.01% | 3361 |
|
|
2022
Q4 | $1.72M | Buy |
2,294,766
+1,585,640
| +224% | +$1.19M | ﹤0.01% | 3371 |
|
|
2022
Q3 | $611K | Sell |
709,126
-8,329
| -1% | -$7.18K | ﹤0.01% | 4122 |
|
|
2022
Q2 | $804K | Buy |
717,455
+2,270
| +0.3% | +$2.54K | ﹤0.01% | 4091 |
|
|
2022
Q1 | $801K | Buy |
715,185
+2,822
| +0.4% | +$3.16K | ﹤0.01% | 4271 |
|
|
2021
Q4 | $1.14M | Buy |
+712,363
| New | +$1.14M | ﹤0.01% | 3927 |
|